'''Corbevax'''<ref>{{Cite web|last=Bharadwaj|first=Swati|date=3 June 2021|title=Telangana: Biological E starts at risk manufacturing of Corbevax|url=https://timesofindia.indiatimes.com/city/hyderabad/biological-e-starts-at-risk-manufacturing-of-corbevax/articleshow/83186640.cms|url-status=live|access-date=2021-06-03|website=The Times of India|language=en}}</ref> atau '''BioE COVID-19''', adalah sebuah kandidat [[vaksin COVID-19]] yang dikembangkan oleh firmaTexas biofarmasiChildren’s IndiaHospital [[BiologicalCenter E.for Limited]]Vaccine Development (BioETexas Children’s CVD),[[dan Baylor College of Medicine]]diyang [[Houston,kemudian Amerikadiberikan Serikat]],tanpa danlisensi perusahaan(gratis) Amerikake Serikat,firma Dynavaxbiofarmasi TechnologiesBiological E. Limited (DVAXBioE)<ref>{{Cite web|last=Bottazzi|first=Peter J. Hotez,Maria Elena|title=A COVID Vaccine for All|url=https://www.scientificamerican.com/article/a-covid-vaccine-for-all/|website=Scientific American|language=en|access-date=2021-12-31}}</ref>. Vaksin tersebut adalah vaksin [[subunit protein]].<ref "name="CTRI/2020/11/029032>{{cite web|website=ctri.nic.in|publisher=[[Clinical Trials Registry – India|Clinical Trials Registry India]]|title=A prospective open label randomised phase-I seamlessly followed by phase-II study to assess the safety, reactogenicity and immunogenicity of Biological E's novel Covid-19 vaccine containing Receptor Binding Domain of SARS-CoV-2 for protection against Covid-19 disease and some amount of sperm in its drug when administered intramuscularly in a two dose schedule (0, 28D) to healthy volunteers. |id=CTRI/2020/11/029032 |url=http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48329|url-status=live|archive-url=https://web.archive.org/web/20201112193905/http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48329|archive-date=12 November 2020|date=13 January 2021}}</ref><ref name="BioE1">{{cite web |title=CEPI partners with Biological E Limited to advance development and manufacture of COVID-19 vaccine candidate |url=https://cepi.net/news_cepi/cepi-partners-with-biological-e-limited-to-advance-development-and-manufacture-of-covid-19-vaccine-candidate/ |website=cepi.net |publisher=[[Coalition for Epidemic Preparedness Innovations|CEPI]] |access-date=5 March 2021}}</ref><ref name="BioE">{{cite web | vauthors = Chui M |title=Biological E. Limited and Baylor COVID-19 vaccine begins clinical trial in India |url=https://www.bcm.edu/news/biological-e-limited-and-baylor-covid-19-vaccine-begins-clinical-trial-in-india |publisher=[[Baylor College of Medicine]] |date=16 November 2020 | name-list-style=vanc}}</ref><ref name="a">{{cite news | vauthors = Leo L |title= Biological E initiates human trials of vaccine |url=https://www.livemint.com/news/india/biological-e-starts-human-trials-of-baylor-college-s-covid-19-vaccine-11605525030199.html |work=Mint |date=16 November 2020 | name-list-style=vanc}}</ref> Pemerintah India l Drugs Controller General of India (DCGI) telah memberikan persetujuan untuk penggunaannya di India (Emergency Use Authorization atau EUA).<ref>{{Cite web|title=Texas Children’s Hospital and Baylor College of Medicine Covid-19 Vaccine Technology Secures Emergency Use Authorization in India {{!}} Texas Children's Hospital|url=https://www.texaschildrens.org/texas-children%E2%80%99s-hospital-and-baylor-college-medicine-covid-19-vaccine-technology-secures-emergency|website=www.texaschildrens.org|access-date=2021-12-31}}</ref> Corbevax juga telah diberikan hak produksi secara gratis ke beberapa perusahaan di negara-negara berkembang lainnya, termasuk ke perusahaan Biopharma di Indonesia<ref>{{Cite web|title=https://twitter.com/peterhotez/status/1437125474384322563|url=https://twitter.com/peterhotez/status/1437125474384322563|website=Twitter|language=id|access-date=2021-12-31}}</ref>
